Experimental Hematology
Volume 38, Issue 4 , Pages 282-291, April 2010

Erythrophagocytosis by angiogenic endothelial cells is enhanced by loss of erythrocyte deformability

  • Marcel H.A.M. Fens

      Affiliations

    • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands
  • ,
  • Gert Storm

      Affiliations

    • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands
  • ,
  • Ralf C.M. Pelgrim

      Affiliations

    • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands
  • ,
  • Anton Ultee

      Affiliations

    • Department of Pathobiology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands
  • ,
  • Annette T. Byrne

      Affiliations

    • Department of Physiology and Medical Physics, Graduate Entry Programme, Royal College of Surgeons in Ireland, Dublin, Ireland
  • ,
  • Carlo A. Gaillard

      Affiliations

    • Department of Internal Medicine, Meander Medical Center, Amersfoort, The Netherlands
  • ,
  • Wouter W. van Solinge

      Affiliations

    • Department of Clinical Chemistry and Haematology, Laboratory for Red Blood Cell Research, University Medical Center Utrecht, Utrecht, The Netherlands
  • ,
  • Raymond M. Schiffelers

      Affiliations

    • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands
    • Corresponding Author InformationOffprint requests to: Raymond M. Schiffelers, Ph.D., Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Sorbonnelaan 16, Utrecht, The Netherlands

Received 16 May 2009; received in revised form 26 January 2010; accepted 2 February 2010. published online 10 February 2010.

Objective

Angiogenic endothelial cells can function as phagocytes, and phagocytosis is initiated via the opsonin lactadherin. In this study, we examined the interaction between lactadherin-opsonized erythrocytes with reduced deformability and angiogenic endothelium, as loss of deformability is characteristic for suicidal and aged erythrocytes.

Materials and Methods

We used the Arg-Gly-Asp (RGD)-modified erythrocyte model and investigated the deformability parameter by cross-linking erythrocyte membranes through treatment with glutaraldehyde. Association in vitro with primary endothelial cells was detected by flow cytometry and visualized by light, fluorescent, and electron microscopy. Involvement of two crucial factors in phagocytosis, αv-integrins and Rho guanosine triphosphatase family member Rac1, was studied using small interfering RNA technology. Modified erythrocytes were administered in vivo into tumor-bearing mice to detect phagocytosis by endothelial cells.

Results

Glutaraldehyde-treated (rigid) RGD-modified erythrocytes showed a strongly enhanced endothelial cell association compared to flexible RGD-modified erythrocytes. Knockdown by small interfering RNA lipoplexes of αv-integrins and Rac1 confirmed classical tethering and internalization of rigid RGD-erythrocytes. Upon in vivo administration, tumor endothelium showed pronounced erythrophagocytosis.

Conclusion

The pronounced phagocytosis of opsonized erythrocytes with reduced deformability by angiogenic growth factor−activated endothelial cells evokes new insights in endothelial cell function and suggests a role for these endothelial cells in (hematological) disorders because of their capacity to clear disordered erythrocytes.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0301-472X(10)00038-X

doi:10.1016/j.exphem.2010.02.001

Experimental Hematology
Volume 38, Issue 4 , Pages 282-291, April 2010